Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CARD
MAX Auto Industry -3x Inverse Leveraged ETN
$17.43
-3.0%
$16.53
$13.72
$36.23
$12.71B-4.41370 shs48 shs
Guardant Health, Inc. stock logo
GH
Guardant Health
$18.10
+4.4%
$19.02
$15.81
$41.06
$2.20B0.871.89 million shs1.80 million shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CARD
MAX Auto Industry -3x Inverse Leveraged ETN
-7.04%-8.04%+23.58%-20.25%+1,795,999,900.00%
Guardant Health, Inc. stock logo
GH
Guardant Health
-1.42%+7.30%+0.52%-23.07%-24.84%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CARD
MAX Auto Industry -3x Inverse Leveraged ETN
N/AN/AN/AN/AN/AN/AN/AN/A
Guardant Health, Inc. stock logo
GH
Guardant Health
4.6276 of 5 stars
4.42.00.04.62.43.30.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CARD
MAX Auto Industry -3x Inverse Leveraged ETN
N/AN/AN/AN/A
Guardant Health, Inc. stock logo
GH
Guardant Health
2.83
Moderate Buy$39.27116.98% Upside

Current Analyst Ratings

Latest SDRY, G4M, GH, and CARD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/24/2024
Guardant Health, Inc. stock logo
GH
Guardant Health
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$28.00
4/15/2024
Guardant Health, Inc. stock logo
GH
Guardant Health
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$32.00 ➝ $28.00
4/5/2024
Guardant Health, Inc. stock logo
GH
Guardant Health
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral
2/26/2024
Guardant Health, Inc. stock logo
GH
Guardant Health
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$40.00 ➝ $30.00
2/23/2024
Guardant Health, Inc. stock logo
GH
Guardant Health
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$60.00 ➝ $45.00
2/23/2024
Guardant Health, Inc. stock logo
GH
Guardant Health
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$50.00 ➝ $45.00
1/29/2024
Guardant Health, Inc. stock logo
GH
Guardant Health
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$43.00 ➝ $37.00
(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CARD
MAX Auto Industry -3x Inverse Leveraged ETN
N/AN/AN/AN/AN/AN/A
Guardant Health, Inc. stock logo
GH
Guardant Health
$563.95M3.91N/AN/A$1.34 per share13.51

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CARD
MAX Auto Industry -3x Inverse Leveraged ETN
N/AN/A0.00N/AN/AN/AN/AN/A
Guardant Health, Inc. stock logo
GH
Guardant Health
-$479.45M-$4.28N/AN/AN/A-85.02%-301.94%-27.65%5/9/2024 (Confirmed)

Latest SDRY, G4M, GH, and CARD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2024N/A
Guardant Health, Inc. stock logo
GH
Guardant Health
-$0.7220N/A+$0.7220N/AN/AN/A  
2/22/2024Q4 2023
Guardant Health, Inc. stock logo
GH
Guardant Health
-$0.93-$1.58-$0.65-$1.58$151.71 million$155.05 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CARD
MAX Auto Industry -3x Inverse Leveraged ETN
N/AN/AN/AN/AN/A
Guardant Health, Inc. stock logo
GH
Guardant Health
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CARD
MAX Auto Industry -3x Inverse Leveraged ETN
N/AN/AN/A
Guardant Health, Inc. stock logo
GH
Guardant Health
7.18
6.54
6.24

Ownership

Institutional Ownership

CompanyInstitutional Ownership
CARD
MAX Auto Industry -3x Inverse Leveraged ETN
N/A
Guardant Health, Inc. stock logo
GH
Guardant Health
92.60%

Insider Ownership

CompanyInsider Ownership
CARD
MAX Auto Industry -3x Inverse Leveraged ETN
N/A
Guardant Health, Inc. stock logo
GH
Guardant Health
6.20%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
CARD
MAX Auto Industry -3x Inverse Leveraged ETN
N/A729.25 millionN/ANot Optionable
Guardant Health, Inc. stock logo
GH
Guardant Health
1,779121.71 million114.17 millionNot Optionable

SDRY, G4M, GH, and CARD Headlines

SourceHeadline
FDA Advisory Panel Review of Guardant Healths Shield(TM) Blood Test to Screen for Colorectal Cancer to Be Held on May 23FDA Advisory Panel Review of Guardant Health's Shield(TM) Blood Test to Screen for Colorectal Cancer to Be Held on May 23
stockhouse.com - April 24 at 12:00 PM
Guardant Health (NASDAQ:GH) Coverage Initiated by Analysts at Craig HallumGuardant Health (NASDAQ:GH) Coverage Initiated by Analysts at Craig Hallum
marketbeat.com - April 24 at 10:46 AM
Guardant Health, Inc. (NASDAQ:GH) Shares Purchased by Sumitomo Mitsui Trust Holdings Inc.Guardant Health, Inc. (NASDAQ:GH) Shares Purchased by Sumitomo Mitsui Trust Holdings Inc.
marketbeat.com - April 24 at 4:54 AM
Guardant Health Sees Unusually High Options Volume (NASDAQ:GH)Guardant Health Sees Unusually High Options Volume (NASDAQ:GH)
americanbankingnews.com - April 23 at 1:06 AM
Guardant Health (NASDAQ:GH) Shares Gap Up to $16.07Guardant Health (NASDAQ:GH) Shares Gap Up to $16.07
marketbeat.com - April 22 at 12:49 PM
Traders Purchase Large Volume of Guardant Health Call Options (NASDAQ:GH)Traders Purchase Large Volume of Guardant Health Call Options (NASDAQ:GH)
marketbeat.com - April 22 at 11:38 AM
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your RadarThese 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
zacks.com - April 22 at 9:56 AM
FDA Advisory Panel Review of Guardant Health’s Shield™ Blood Test to Screen for Colorectal Cancer to Be Held on May 23FDA Advisory Panel Review of Guardant Health’s Shield™ Blood Test to Screen for Colorectal Cancer to Be Held on May 23
finance.yahoo.com - April 22 at 9:14 AM
FDA Advisory Panel Review of Guardant Healths Shield™ Blood Test to Screen for Colorectal Cancer to Be Held on May 23FDA Advisory Panel Review of Guardant Health's Shield™ Blood Test to Screen for Colorectal Cancer to Be Held on May 23
businesswire.com - April 22 at 8:52 AM
Federated Hermes Inc. Sells 202,300 Shares of Guardant Health, Inc. (NASDAQ:GH)Federated Hermes Inc. Sells 202,300 Shares of Guardant Health, Inc. (NASDAQ:GH)
marketbeat.com - April 22 at 5:56 AM
Guardant Health to Report First Quarter 2024 Financial Results on May 9, 2024Guardant Health to Report First Quarter 2024 Financial Results on May 9, 2024
businesswire.com - April 18 at 4:05 PM
Mass. General Hospital granted unanimous approval to add dozens of inpatient bedsMass. General Hospital granted unanimous approval to add dozens of inpatient beds
msn.com - April 17 at 8:36 PM
Romance Is In The Air On General HospitalRomance Is In The Air On General Hospital
msn.com - April 17 at 8:36 PM
General Hospital Spoilers: Will Cyrus Decide Sonnys Prison Fate?General Hospital Spoilers: Will Cyrus Decide Sonny's Prison Fate?
msn.com - April 17 at 8:36 PM
Guardant Health (NASDAQ:GH) Trading Up 3.4%Guardant Health (NASDAQ:GH) Trading Up 3.4%
marketbeat.com - April 17 at 2:36 PM
Guardant Health (NASDAQ:GH) Reaches New 1-Year Low After Analyst DowngradeGuardant Health (NASDAQ:GH) Reaches New 1-Year Low After Analyst Downgrade
americanbankingnews.com - April 17 at 1:08 AM
Guardant Health (NASDAQ:GH) Sets New 12-Month Low Following Analyst DowngradeGuardant Health (NASDAQ:GH) Sets New 12-Month Low Following Analyst Downgrade
marketbeat.com - April 16 at 10:35 AM
Guardant Health (NASDAQ:GH) Price Target Cut to $28.00 by Analysts at The Goldman Sachs GroupGuardant Health (NASDAQ:GH) Price Target Cut to $28.00 by Analysts at The Goldman Sachs Group
americanbankingnews.com - April 16 at 4:48 AM
Guardant Health (NASDAQ:GH) PT Lowered to $28.00 at The Goldman Sachs GroupGuardant Health (NASDAQ:GH) PT Lowered to $28.00 at The Goldman Sachs Group
marketbeat.com - April 15 at 11:21 AM
General Hospital Video Preview: Decisions, Disrespect, and DeceptionGeneral Hospital Video Preview: Decisions, Disrespect, and Deception
yahoo.com - April 12 at 2:02 PM
What The Heck Just Happened On General Hospital?What The Heck Just Happened On General Hospital?
msn.com - April 12 at 2:02 PM
6,178,812 Shares in Guardant Health, Inc. (NASDAQ:GH) Purchased by Baillie Gifford & Co.6,178,812 Shares in Guardant Health, Inc. (NASDAQ:GH) Purchased by Baillie Gifford & Co.
marketbeat.com - April 10 at 8:24 AM
Guardant Health (NASDAQ:GH) Stock Price Up 4.9%Guardant Health (NASDAQ:GH) Stock Price Up 4.9%
marketbeat.com - April 8 at 2:30 PM
Guggenheim Reaffirms Neutral Rating for Guardant Health (NASDAQ:GH)Guggenheim Reaffirms Neutral Rating for Guardant Health (NASDAQ:GH)
marketbeat.com - April 5 at 10:27 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

MAX Auto Industry -3x Inverse Leveraged ETN

NYSEARCA:CARD
The MAX Auto Industry -3x Inverse Leveraged ETN (CARD) is an exchange-traded fund that is based on the Prime Auto Industry index. The fund is an exchange-traded note that tracks -3x the daily price movements of an index consisting of US-listed companies in the broader auto industry ecosystem. The index selects equities by market-cap and weights the resulting portfolio by liquidity. CARD was launched on Jun 30, 2023 and is issued by Max.
Guardant Health logo

Guardant Health

NASDAQ:GH
Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.